Nasdaq · CIK 0001509261
RZLT Rezolute, Inc.
Insider trading from SEC Form 4. Last filing Mar 31, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at Rezolute, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 42Moderate | buy 2 | Elam Nevan C CEO | $35k | 12,302 | +6% | - | |
| 40Moderate | buy 2 | Evans Daron CFO | $58k | 20,000 | +9% | - | |
| 24Weak | buy | Hogenhuis Wladimir director | $47k | 10,000 | +15% | - | |
| 46Moderate | buy | Kim Young-Jin director | $5.0M | 1,250,000 | +21% | - | |
| 36Weak | buy | Evans Daron CFO | $43k | 10,000 | +7% | - | |
| 31Weak | buy | Evans Daron CFO | $41k | 9,000 | +7% | - | |
| 32Weak | buy | Evans Daron CFO | $53k | 10,549 | +9% | - |
Transactions
The last 21 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Elam Nevan C CEO | POpen-market purchase Common Shares | +12,302 | $2.85 | $35k | 224,119 | Mar 31, 2025 |
| Mar 26, 2025 | Evans Daron CFO | POpen-market purchase Common Shares | +10,000 | $2.89 | $29k | 237,900 | Mar 28, 2025 |
| Mar 26, 2025 | Evans Daron CFO | POpen-market purchase Common Sharesindirect: Minor child #1 | +10,000 | $2.88 | $29k | 23,000 | Mar 28, 2025 |
| Mar 25, 2025 | Harris Erik director | AGrant or award Director Stock Option (Right to Buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Mar 26, 2025 |
| Feb 16, 2025 | Hogenhuis Wladimir director | AGrant or award Common Shares | +25,500 | $0.00 | $0 | 67,267 | Feb 20, 2025 |
| Feb 18, 2025 | Hogenhuis Wladimir director | POpen-market purchase Common Shares | +10,000 | $4.70 | $47k | 77,267 | Feb 20, 2025 |
| Feb 16, 2025 | Hogenhuis Wladimir director | AGrant or award Director Stock Option (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Feb 20, 2025 |
| Feb 16, 2025 | FAUCHET PHILIPPE director | AGrant or award Common Shares | +25,500 | $0.00 | $0 | 25,500 | Feb 19, 2025 |
| Feb 16, 2025 | Kim Young-Jin director | AGrant or award Common Shares | +25,500 | $0.00 | $0 | 140,950 | Feb 19, 2025 |
| Feb 16, 2025 | KREHER NERISSA director | AGrant or award Common Shares | +25,500 | $0.00 | $0 | 25,500 | Feb 19, 2025 |
| Feb 16, 2025 | Evans Daron CFO | AGrant or award Common Shares | +77,000 | $0.00 | $0 | 227,900 | Feb 19, 2025 |
| Feb 16, 2025 | Elam Nevan C CEO | AGrant or award Common Shares | +204,000 | $0.00 | $0 | 211,817 | Feb 19, 2025 |
| Feb 16, 2025 | FAUCHET PHILIPPE director | AGrant or award Director Stock Option (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Feb 19, 2025 |
| Feb 16, 2025 | Elam Nevan C CEO | AGrant or award Employee Stock Option (Right to Buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Feb 19, 2025 |
| Feb 16, 2025 | KREHER NERISSA director | AGrant or award Director Stock Option (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Feb 19, 2025 |
| Jun 25, 2024 | Kim Young-Jin director | POpen-market purchase Common Sharesindirect: Held by Handok, Inc. | +1,250,000 | $4.00 | $5.0M | 7,192,617 | Feb 19, 2025 |
| Feb 16, 2025 | Kim Young-Jin director | AGrant or award Director Stock Option (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Feb 19, 2025 |
| Feb 16, 2025 | Evans Daron CFO | AGrant or award Employee Stock Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Feb 19, 2025 |
| Dec 18, 2024 | Evans Daron CFO | POpen-market purchase Common Shares | +10,000 | $4.29 | $43k | 150,900 | Dec 18, 2024 |
| Dec 12, 2024 | Evans Daron CFO | POpen-market purchase Common Shares | +9,000 | $4.60 | $41k | 140,900 | Dec 12, 2024 |
| Dec 9, 2025 | Evans Daron CFO | POpen-market purchase Common Shares | +10,549 | $5.04 | $53k | 131,900 | Dec 10, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Elam Nevan CCEO
- Evans DaronCFO
- FAUCHET PHILIPPEdirector
- Harris Erikofficer, director
- Hogenhuis Wladimirdirector
- KREHER NERISSAdirector
- Kim Young-Jindirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.